Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia

Issue title: Selected papers of the 39th Conference of the German Society for Clinical Microcirculation and Hemorheology, 6-7 November 2020, Hannover, Germany

Guest editors: B. Hiebl, A. Krüger-Genge and F. Jung

Article type: Research Article

Authors: Jung, E.M.^{a; *} | Wertheimer, T.^b | Putz, F.J.^c | Jung, F.^d | Kammerer, S.^a | Pregler, B.^a | Luerken, L.^a | Stroszczynski, C.^a | Beyer, L.^a

Affiliations: [a] Institute of Diagnostic Radiology, University Medical Center Regensburg, Regensburg, Germany | [b] Department for Internal Medicine III, Hematology and Oncology, University Medical Center Regensburg, Regensburg, Germany | [c] Department of Nephrology, University Medical Center Regensburg, Regensburg, Germany | [d] Brandenburgische Technische Universität Cottbus-Senftenberg, Institute of Biotechnology, Cottbus, Germany

Correspondence: [*] Corresponding author: Ernst Michael Jung, Institute of Diagnostic Radiology, University Medical Center Regensburg, Franz-Josef-Strauss Allee 11, 93042 Regensburg, Germany. E-mail: ernst-michael.jung@ukr.de.

Abstract: AIM:To evaluate the use of dynamic contrast enhanced ultrasound (CEUS) with parametric color-coded imaging and time intensity curve analysis (TIC) for planning and follow-up after prostate arterial embolization (PAE). MATERIAL/METHOD:Before and after selective iliacal embolization by PAE with a follow up of 6 months 18 male patients (43–78 years, mean 63±3.5 years) with histopathological proven benign prostate hyperplasia were examined by one experienced examiner. A multifrequency high resolution probe (1–6 MHz) was used for transabdominal ultrasound and CEUS with bolus injections of 2.4 ml sulphur-hexafluoride microbubbles. Independent evaluation of color-coded parametric imaging before and after PAE by in PACS stored DICOM loops from arterial phase (10–15 s) up to 1min were performed. Criteria for successful treatment were reduction of early arterial enhancement by changes of time to peak (TTP) and area under the curve (AUC) by measurements in 8 regions of interest (ROI) of 5 mm in diameter at the margin and in the center and changes from hyperenhancement in parametric imaging (perfusion evaluation of arterial enhancement over 15 s) from red and yellow to blue and green by partial infarctions. Reference imaging method was the contrast high resolution 3 tesla magnetic resonance tomography (MRI) using 3D vibe sequences before and after PAE and for the follow up after 3 and 6 months. RESULTS:PAE was technically and clinically successful in all 18 patients with less clinical symptoms and reduction of the gland volume. In all cases color-coded CEUS parametric imaging was able to evaluate partial infarction after embolization with changes from red and yellow to green and blue colors in the embolization areas. Relevant changes could be evaluated for TIC-analysis of CEUS with reduced arterial enhancement in the arterial phase and prolonged enhancement of up to 1 min with significant changes (p = 0.0024). The area under the curve (AUC) decreased from 676±255.04 rU (160 rU–1049 rU) before PAE to 370.43±255.19 rU (45 rU–858 rU) after PAE. Time to peak (TTP) did not change significantly (p = 0.6877); TTP before PAE was 25.82±9.04 s (12.3 s–42.5 s) and after PAE 24.43±9.10 s (12–39 s). Prostate volume decreased significantly (p = 0.0045) from 86.93±34.98 ml (30–139 ml) before PAE to 50.57±26.26 ml (19–117 ml) after PAE. There were no major complications and, in most cases (14/18) a volume reduction of the benign prostate hyperplasia occurred. CONCLUSION:Performed by an experienced examiner CEUS with parametric imaging and TIC-analysis is highly useful to further establish prostatic artery embolization (PAE) as a successful minimal invasive treatment of benign prostatic hyperplasia.

Keywords: Contrast enhanced ultrasound (CEUS), parametric imaging, time intensity curve analysis (TIC), prostate arterial embolization (PAE)

DOI: 10.3233/CH-209202

Journal: Clinical Hemorheology and Microcirculation, vol. 76, no. 2, pp. 143-153, 2020